文献速递基础与转化研究流行病学与生物统计

外显子组测序用于非免疫性胎儿水肿的产前诊断

Exome Sequencing for Prenatal Diagnosis in Nonimmune Hydrops Fetalis.
PubMed 文献 · N Engl J Med · 2020-10-07

该研究评估了127例连续不明原因非免疫性胎儿水肿(NIHF)病例,采用外显子组测序检测致病或可能致病变异。结果显示29%(37/127)的病例获得诊断,其中RASopathies占30%,遗传方式以常染色体显性为主(68%),且多数为新发变异。

要点

  • 外显子组测序在不明原因NIHF中诊断率约29%。
  • RASopathies是最常见诊断类别,占遗传诊断的30%。
  • 常染色体显性诊断中88%为新发变异,遗传咨询需注意。

核心结论

  • 在127例不明原因非免疫性胎儿水肿病例中,约三分之一可通过外显子组测序检出致病或可能致病变异。

研究设计与样本

  • 研究纳入127例连续的不明原因非免疫性胎儿水肿病例,定义依据为胎儿腹水、胸膜或心包积液、皮肤水肿、囊性水瘤、颈项透明层增厚或其组合。

主要发现

  • 37/127例(29%)检出诊断性遗传变异。
  • 诊断变异中RAS-MAPK信号通路疾病(RASopathies)占30%,先天代谢缺陷和肌肉骨骼疾病各占11%,淋巴、神经发育、心血管和血液疾病各占8%。
  • 诊断变异病例中68%(25/37)为常染色体显性,其中12%遗传、88%为新发;27%(10/37)为常染色体隐性,其中95%遗传、5%为新发;另各有1例为遗传性X连锁隐性和遗传方式不确定。
  • 额外12例检出可能诊断性变异。

关键数值与推荐

  • 诊断性变异依据美国医学遗传学与基因组学学会(ACMG)标准分类为致病或可能致病。

临床怎么用

  • 对不明原因非免疫性胎儿水肿,外显子组测序可提供产前遗传诊断,辅助预后评估和遗传咨询。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The cause of most fetal anomalies is not determined prenatally. Exome sequencing has transformed genetic diagnosis after birth, but its usefulness for prenatal diagnosis is still emerging. Nonimmune hydrops fetalis (NIHF), a fetal abnormality that is often lethal, has numerous genetic causes; the extent to which exome sequencing can aid in its diagnosis is unclear. METHODS: We evaluated a series of 127 consecutive unexplained cases of NIHF that were defined by the presence of fetal ascites, pleural or pericardial effusions, skin edema, cystic hygroma, increased nuchal translucency, or a combination of these conditions. The primary outcome was the diagnostic yield of exome sequencing for detecting genetic variants that were classified as either pathogenic or likely pathogenic according to the criteria of the American College of Medical Genetics and Genomics. Secondary outcomes were the percentage of cases associated with specific genetic disorders and the proportion of variants that were inherited. RESULTS: In 37 of the 127 cases (29%), we identified diagnostic genetic variants, including those for disorders affecting the RAS-MAPK cell-signaling pathway (known as RASopathies) (30% of the genetic diagnoses); inborn errors of metabolism and musculoskeletal disorders (11% each); lymphatic, neurodevelopmental, cardiovascular, and hematologic disorders (8% each); and others. Prognoses ranged from a relatively mild outcome to death during the perinatal period. Overall, 68% of the cases (25 of 37) with diagnostic variants were autosomal dominant (of which 12% were inherited and 88% were de novo), 27% (10 of 37) were autosomal recessive (of which 95% were inherited and 5% were de novo), 1 was inherited X-linked recessive, and 1 was of uncertain inheritance. We identified potentially diagnostic variants in an additional 12 cases. CONCLUSIONS: In this large case series of 127 fetuses with unexplained NIHF, we identified a diagnostic genetic variant in approximately one third of the cases. (Funded by the UCSF Center for Maternal-Fetal Precision Medicine and others; ClinicalTrials.gov number, NCT03412760.).

来源:N Engl J Med,查看原文。版权归原作者所有。

引用

  1. Sparks TN, Lianoglou BR, Adami RR, et al. Exome Sequencing for Prenatal Diagnosis in Nonimmune Hydrops Fetalis. N Engl J Med. 2020. PMID: 33027564. doi:10.1056/NEJMoa2023643

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。